This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
NextGen's (NXGN) HDH to Facilitate Health Information Exchange
by Zacks Equity Research
NextGen's (NXGN) HDH has been chosen by HI-BRIDGE HIE for secure sharing of patient health data from multiple sources.
Abbott (ABT) Launches Immunity Boosting Hydration Solution
by Zacks Equity Research
Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.
Masimo (MASI) Releases Favorable Findings on Pulse Oximetry
by Zacks Equity Research
Researchers on probe discover that the use of Masimo's (MASI) SpHb was related to the lower rate of postoperative transfusion, minimal duration of ICU stay and other better outcomes.
NEOGEN (NEOG) Launches DNA Screening Tool for Canine Care
by Zacks Equity Research
NEOGEN's (NEOG) latest DNA screening tool is expected to aid veterinarians to provide healthy lifestyle recommendations for a longer and happier life for each pet and its family.
Here's Why You Should Retain Fresenius Medical (FMS) Stock
by Zacks Equity Research
Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.
Cerner's (CERN) Simplified Digital Tools to Aid Health Systems
by Zacks Equity Research
Cerner (CERN) offers centralized digital ordering and monitoring for clients in order to help health systems.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $471.39, moving +0.57% from the previous trading session.
Zimmer Biomet (ZBH), HSS Partner to Advance Remote Patient Care
by Zacks Equity Research
Zimmer Biomet's (ZBH) mymobility with Apple Watch platform aids in transforming virtual patient care via the latest partnership with HSS.
Here's Why You Should Hold on to McKesson (MCK) Stock Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
Simbec-Orion to Adopt Veeva's (VEEV) Vault Applications
by Zacks Equity Research
Veeva's (VEEV) clinical solutions will offer Simbec-Orion real-time insights into studies in phases to accelerate trial execution.
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Abbott Laboratories, Owens & Minor, Thermo Fisher Scientific, Quidel Corp and Hologic
LabCorp's (LH) Pixel Kit Gets EUA for Over-the-Counter Use
by Zacks Equity Research
This approval is expected to increase access to LabCorp's (LH) COVID-19 testing, thereby broadening its customer base.
Cerner's (CERN) Deal to Make Clinical Trials More Accessible
by Zacks Equity Research
Cerner (CERN) inks deal with Elligo Health Research to make clinical trials more accessible, while minimizing costs.
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
by Zacks Equity Research
Investors grew bullish on Nevro's (NVRO) prospects, courtesy of the stock's solid prospects.
Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin
by Zacks Equity Research
Zacks.com featured highlights include: Lennar Corp, TeleTech Holdings, Activision Blizzard, Thermo Fisher Scientific and ParkerHannifin
Medtronic (MDT) Carpediem to Tap Pediatric Kidney Care Market
by Zacks Equity Research
Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.
Bruker (BRKR) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.
Illumina (ILMN)-Harvard Pilgrim Partner to Expand WGS Access
by Zacks Equity Research
Illumina (ILMN) signs agreement to expand the availability of WGS to enable faster and cost-effective diagnosis of genetic diseases in children.
4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021
by Trina Mukherjee
Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.
HealthEquity (HQY) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity (HQY) delivers strong growth in Service, Custodial and Interchange segments in Q3.
3 Reasons Growth Investors Will Love Thermo Fisher (TMO)
by Zacks Equity Research
Thermo Fisher (TMO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
QIAGEN (QGEN) Launches RUO Solution to Explore Immune Response
by Zacks Equity Research
QIAGEN's (QGEN) latest RUO solution is expected to provide better insights into the course of the COVID-19 infection and aid in vaccine development and deployment.
LabCorp (LH) Covance Arms Shows Momentum Amid COVID-19 Woes
by Zacks Equity Research
In oncology too, LabCorp (LH) receives a significant award to be the partner of choice for late-stage oncology studies from a major pharmaceutical company.
NuVasive (NUVA) Focuses on Cervical Spine Portfolio Expansion
by Zacks Equity Research
The ACP system within NuVasive (NUVA) C360 is targeted to reduce common postoperative complications such as dysphagia, malalignment and adjacent level ossification.
5 Top-Ranked Stocks With Solid Dividend Growth to Bet On
by Sweta Killa
These dividend growth stocks have superior fundamentals, making them quality and promising investments for the long term.